www.marinuspharma.com/board.html -
[Cached Version]
Published on: 10/9/2009
Last Visited: 10/9/2009
Stephen Bloch, M.D
...
Stephen Bloch, M.D.
Chairman
Stephen Bloch joined Canaan Partners in June 2002, initially as a Ewing Marion Kauffman Fellow.
His investment targets include biopharmaceuticals (therapeutics and diagnostics), medical devices and healthcare infrastructure.
Dr. Bloch currently serves on the Board of Directors for Advanced Biohealing, Amicus Therapeutics, Marinus Pharmaceuticals, OmniSonics Medical Technologies and Viacor.
Prior to joining Canaan, Dr. Bloch was a medical entrepreneur and practicing physician.
He founded and was CEO of Radiology Management Sciences, a risk manager of diagnostic imaging services for health plans and provider networks.
As medical director, he helped start Omnisonics Medical Technologies which is developing breakthrough products using acoustic energy for the treatment of vascular occlusive diseases.
Additionally, he co-founded TeleRad, a teleradiology services company, and was an initial investor in OpenAir.com, an enterprise software company for professional services firms.
Dr. Bloch started his business career as a strategic consultant with Arthur D. Little focused on pharmaceuticals and medical devices.
...
Dr. Bloch received his medical training as a radiologist at The Massachusetts General Hospital/Harvard Medical School and in internal medicine at The Lenox Hill Hospital/Cornell Medical School.
He received his medical degree from the University of Rochester.
He also received a M.A. in history of science and public policy from Harvard University and an A.B. degree in history from Dartmouth College.
Dr. Bloch became Chairman of the Marinus Pharmaceuticals board in October 2007.